DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹50 Cr | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr | ₹1,987 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹193 Cr |
| Mar2023 | ₹-1,045 Cr |
| Mar2022 | ₹-816 Cr |
| Mar2021 | ₹1,987 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | -74.09 | |
| Mar2024 | ₹193 Cr | Positive | |
| Mar2023 | ₹-1,045 Cr | Negative | |
| Mar2022 | ₹-816 Cr | Negative | |
| Mar2021 | ₹1,987 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹167,255.7 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| MANKIND PHARMA | ₹91,013.2 Cr | 9.3% | 7.3% | -2.3% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 2.4% |
6% |
12.4% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses